MedTrace Logo

Kinetic of Compounds of a Melatonin-based Formulation in Healthy Subjects

NCT05419466 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2023-11-13

No results posted yet for this study

Summary

This study is conducted to clinically document the melatonin and zinc bioavailability of a dietary supplement containing delayed release melatonin, zinc and lemon balm

Conditions

  • Melatonin Bioavailability

Interventions

DIETARY_SUPPLEMENT

dietary supplement, 1 tablet containing delayed release melatonin, zinc and lemon balm

dietary supplement is dosed at 1.9 mg of melatonin, 10 mg of zinc and 200 mg of lemon balm for one tablet

Sponsors & Collaborators

  • Larena SAS

    lead INDUSTRY

Principal Investigators

  • Bruno Claustrat · PiLeJe

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-14
Primary Completion
2023-05-22
Completion
2023-05-22

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05419466 on ClinicalTrials.gov